HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

QYUNS-B

16.970

+0.1901.13%

Volume:47.40K

Turnover:797.00K

Market Cap:3.78B

PE:10.32

High:17.040

Open:16.780

Low:16.580

Close:16.780

52wk High:36.500

52wk Low:13.210

Shares:223.00M

HK Float Shares:223.00M

Volume Ratio:0.29

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.645

ROE:101.58%

ROA:22.97%

PB:3.77

PE(LYR):10.32

PS:3.17

Loading ...

Overview Company News Filings

QYUNS-B (02509) Allocates Funds to Wealth Management Products

Qyuns Therapeutics Co Ltd - to Subscribe Pdb Wealth Product With RMB100 Mln Principal Maturing Oct 29, 2026

THOMSON REUTERS

Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利，全球化布局与核心产品管线齐头并进

Bulletin Express

QYUNS-B Shares Surge Over 8% Following Turn to Profit Last Year; Projected Sales of Key Product Near RMB 500 Million This Year

QYUNS-B Reports Stable Share Capital and Confirms Public Float Compliance for March 2026

Bulletin Express

Shareholders Will Be Pleased With The Quality of Qyuns Therapeutics' (HKG:2509) Earnings

Simply Wall St.

Qyuns Therapeutics Forms Strategy and Development Committee to Sharpen Long-Term Planning

QYUNS-B Reports Over 400% Revenue Surge in 2025, Swings to Adjusted Profit of 356 Million Yuan

Qyuns Therapeutics - FY Revenue RMB807 Mln

THOMSON REUTERS

Qyuns Therapeutics Invests 100 Million Yuan in Wealth Management Product

MT Newswires Live

BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million Principal

QYUNS-B (02509) Invests 100 Million Yuan in Wealth Management Product

Qyuns Therapeutics Co Ltd - to Subscribe for Pdb Wealth Management Product With RMB100 Mln Principal

THOMSON REUTERS

GTHT Securities Initiates Coverage on QYUNS-B with "Buy" Rating, Highlights Focus on Autoimmune Therapy

Qyuns Therapeutics' Arthritis Drug Crusekitug Accepted for Review in China; Shares Jump 11%

MT Newswires Live

BRIEF-Qyuns Therapeutics Says New Drug Application Of Crusekitug (Qx002n) Accepted By NMPA

QYUNS-B (02509) Gains NMPA Acceptance for Lusekizumab (QX002N) New Drug Application Targeting Active Ankylosing Spondylitis in Adults

Qyuns Therapeutics’ Crusekitug NDA for adult ankylosing spondylitis accepted by China’s NMPA

Qyuns Therapeutics Co Ltd - New Drug Application of Crusekitug (QX002n) for Treatment of Active Ankylosing Spondylitis in Adults Accepted by Nmpa

THOMSON REUTERS

QYUNS-B (02509) Announces Monthly Return for February 2026

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02509/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":16.97,"timestamp":1787299500045,"preClose":16.78,"halted":0,"volume":47400,"delay":0,"changeRate":0.011323003575685204,"floatShares":223000000,"shares":223000000,"eps":1.6449170880865578,"marketStatus":"Not Yet Opened","change":0.19,"latestTime":"08-21 16:05:00","open":16.78,"high":17.04,"low":16.58,"amount":797000,"amplitude":0.027414,"askPrice":17,"askSize":1000,"bidPrice":16.83,"bidSize":600,"shortable":3,"etf":0,"ttmEps":2.813551349837313,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":16.78,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.2883913361265991,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":223000000,"roa":"22.97%","roe":"101.58%","lyrEps":1.644917,"volumeRatio":0.2883913361265991,"shares":223000000,"dividePrice":0,"high":17.04,"amplitude":0.027414,"preClose":16.78,"low":16.58,"week52Low":13.21,"pbRate":"3.77","psRate":"3.17","week52High":36.5,"institutionHeld":0,"latestPrice":16.97,"committee":-0.25,"eps":1.6449170880865578,"divideRate":0,"volume":47400,"delay":0,"ttmEps":2.813551349837313,"open":16.78,"prevYearClose":18.78,"prevWeekClose":16.97,"prevMonthClose":16.3,"prevQuarterClose":14.18,"fiveDayClose":17.64,"twentyDayClose":16.2,"sixtyDayClose":16.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-03-27","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769011200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2026-08-21","current":6.030078,"percent":0.839798,"low":-38.274716,"twenty":-20.041187,"median":-9.088801,"eighty":-3.461369,"high":13.150203,"avg":-9.116415,"sd":11.537008,"marketCap":3790626234},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-14","current":-22.685433,"twenty":-12.458841,"median":-9.113568,"eighty":-5.155799,"marketCap":4764920384},{"date":"2025-11-21","current":-21.57415,"twenty":-12.521958,"median":-9.126184,"eighty":-5.17154,"marketCap":4529392000},{"date":"2025-11-28","current":-24.204574,"twenty":-12.94929,"median":-9.16505,"eighty":-5.177501,"marketCap":5100095392},{"date":"2025-12-05","current":-22.466634,"twenty":-13.164946,"median":-9.191702,"eighty":-5.178705,"marketCap":4742036512},{"date":"2025-12-12","current":-22.1097,"twenty":-13.511538,"median":-9.209948,"eighty":-5.212195,"marketCap":4675330264},{"date":"2025-12-19","current":-20.041803,"twenty":-17.63398,"median":-9.232059,"eighty":-5.270292,"marketCap":4248039442},{"date":"2025-12-24","current":-19.36285,"twenty":-19.558586,"median":-9.239461,"eighty":-5.282537,"marketCap":4116913158},{"date":"2026-01-02","current":-20.737965,"twenty":-19.704926,"median":-9.253177,"eighty":-5.315175,"marketCap":4426642484},{"date":"2026-01-09","current":-23.204245,"twenty":-20.357213,"median":-9.278386,"eighty":-5.378549,"marketCap":4965417516},{"date":"2026-01-16","current":-24.098803,"twenty":-20.760618,"median":-9.31719,"eighty":-5.397051,"marketCap":5173599760},{"date":"2026-01-23","current":-22.922252,"twenty":-21.536475,"median":-9.368149,"eighty":-5.401271,"marketCap":4916293200},{"date":"2026-01-30","current":-21.794057,"twenty":-21.687913,"median":-9.424295,"eighty":-5.425026,"marketCap":4695690300},{"date":"2026-02-06","current":-20.334967,"twenty":-21.659361,"median":-9.513128,"eighty":-5.511946,"marketCap":4392431440},{"date":"2026-02-13","current":-21.335749,"twenty":-21.659361,"median":-9.528371,"eighty":-5.55032,"marketCap":4635075264},{"date":"2026-02-20","current":-20.973148,"twenty":-21.649543,"median":-9.534937,"eighty":-5.562312,"marketCap":4549739576},{"date":"2026-02-27","current":-17.376769,"twenty":-21.609505,"median":-9.566812,"eighty":-5.593401,"marketCap":3810912172},{"date":"2026-03-06","current":-17.920587,"twenty":-21.564731,"median":-9.594832,"eighty":-5.599011,"marketCap":3898493536},{"date":"2026-03-13","current":-18.300829,"twenty":-21.488875,"median":-9.614895,"eighty":-5.602974,"marketCap":3999548956},{"date":"2026-03-20","current":-18.380704,"twenty":-21.336069,"median":-9.649601,"eighty":-5.606602,"marketCap":4001794632},{"date":"2026-03-27","current":-20.040776,"twenty":-21.318389,"median":-9.681606,"eighty":-5.612646,"marketCap":4352120088},{"date":"2026-04-02","current":12.478766,"twenty":-21.24895,"median":-9.659156,"eighty":-5.598207,"marketCap":4464403888},{"date":"2026-04-10","current":12.781914,"twenty":-21.241413,"median":-9.628889,"eighty":-5.5458,"marketCap":4608127152},{"date":"2026-04-17","current":12.751644,"twenty":-21.234144,"median":-9.610023,"eighty":-5.395876,"marketCap":4599144448},{"date":"2026-04-24","current":11.21309,"twenty":-21.216401,"median":-9.58505,"eighty":-5.228839,"marketCap":4044462476},{"date":"2026-04-30","current":10.7021,"twenty":-21.203518,"median":-9.560506,"eighty":-5.17154,"marketCap":3862562720},{"date":"2026-05-08","current":10.358859,"twenty":-21.109524,"median":-9.533439,"eighty":-5.114765,"marketCap":3750278920},{"date":"2026-05-15","current":10.61627,"twenty":-20.963352,"median":-9.513744,"eighty":-4.927569,"marketCap":3853580016},{"date":"2026-05-22","current":9.629856,"twenty":-20.934581,"median":-9.462151,"eighty":-4.874282,"marketCap":3487534828},{"date":"2026-05-29","current":10.418336,"twenty":-20.904691,"median":-9.37169,"eighty":-4.456501,"marketCap":3786209736},{"date":"2026-06-05","current":9.397468,"twenty":-20.865916,"median":-9.353096,"eighty":-4.408713,"marketCap":3420164548},{"date":"2026-06-12","current":9.885443,"twenty":-20.842881,"median":-9.289241,"eighty":-4.354459,"marketCap":3595327276},{"date":"2026-06-18","current":8.798669,"twenty":-20.809475,"median":-9.260665,"eighty":-4.275598,"marketCap":3206825328},{"date":"2026-06-26","current":8.4741,"twenty":-20.737965,"median":-9.247135,"eighty":-4.113712,"marketCap":3074330444},{"date":"2026-07-03","current":9.525463,"twenty":-20.637607,"median":-9.233055,"eighty":-3.977556,"marketCap":3458341040},{"date":"2026-07-10","current":9.469045,"twenty":-20.557354,"median":-9.218198,"eighty":-3.819713,"marketCap":3433638604},{"date":"2026-07-17","current":9.867437,"twenty":-20.504561,"median":-9.194332,"eighty":-3.699682,"marketCap":3590835924},{"date":"2026-07-24","current":9.994782,"twenty":-20.472909,"median":-9.165919,"eighty":-3.658551,"marketCap":3637995120},{"date":"2026-07-31","current":9.98398,"twenty":-20.387953,"median":-9.159435,"eighty":-3.646486,"marketCap":3640966860},{"date":"2026-08-07","current":10.600412,"twenty":-20.327675,"median":-9.121996,"eighty":-3.503724,"marketCap":3873273948},{"date":"2026-08-14","current":10.770175,"twenty":-20.154207,"median":-9.100722,"eighty":-3.481151,"marketCap":3940285608},{"date":"2026-08-21","current":5.952896,"twenty":-20.041187,"median":-9.088801,"eighty":-3.461369,"marketCap":3790626234}],"updateTime":1787510768470},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196338169","title":"QYUNS-B (02509) Allocates Funds to Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1196338169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196338169?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:31","pubTimestamp":1777462260,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on April 29, 2026, to efficiently utilize its idle capital, the company entered into subscription agreements with SPD Bank to acquire several wealth management products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513878","title":"Qyuns Therapeutics Co Ltd - to Subscribe Pdb Wealth Product With RMB100 Mln Principal Maturing Oct 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513878?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:23","pubTimestamp":1777461830,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C0TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121393309","title":"Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利，全球化布局与核心产品管线齐头并进","url":"https://stock-news.laohu8.com/highlight/detail?id=1121393309","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121393309?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:31","pubTimestamp":1777282264,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd.（以下简称“公司”）于2025年度实现显著业绩增长和结构性进展，全年收入同比增长408.2%至人民币8.0696亿元（2024年：1.5879亿元），并从上一年度净亏损人民币3.4969亿元成功扭转为净利润人民币3.0744亿元，标志着公司首次实现全年盈利。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利，全球化布局与核心产品管线齐头并进","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137432614","title":"QYUNS-B Shares Surge Over 8% Following Turn to Profit Last Year; Projected Sales of Key Product Near RMB 500 Million This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1137432614","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137432614?lang=en_us&edition=fundamental","pubTime":"2026-04-15 10:56","pubTimestamp":1776221806,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) rose more than 8% during the trading session. At the time of writing, the stock was up 7.22% to HK$20.78, with a turnover of HK$10.18 million. The company's 2025 results showed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4579","LX","LU1235295612.USD","VXUS","BK4166","02509","BK4531","LU1046422090.SGD","BK4588","BK4585","LU0049112450.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179832135","title":"QYUNS-B Reports Stable Share Capital and Confirms Public Float Compliance for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1179832135","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179832135?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:48","pubTimestamp":1775731680,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited on 9 April 2026, covering the month ended 31 March 2026. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624205698","title":"Shareholders Will Be Pleased With The Quality of Qyuns Therapeutics' (HKG:2509) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2624205698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624205698?lang=en_us&edition=fundamental","pubTime":"2026-04-04 06:40","pubTimestamp":1775256021,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. ( HKG:2509 ) just reported healthy earnings but the stock price didn't move much. We think...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/shareholders-will-be-pleased-with-the-quality-of-qyuns-thera","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/shareholders-will-be-pleased-with-the-quality-of-qyuns-thera","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622876838","title":"Qyuns Therapeutics Forms Strategy and Development Committee to Sharpen Long-Term Planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2622876838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622876838?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:22","pubTimestamp":1774624927,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) just unveiled an update. Qyuns Therapeutics has created a Strategy and Development Committee un...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-forms-strategy-and-development-committee-to-sharpen-long-term-planning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-forms-strategy-and-development-committee-to-sharpen-long-term-planning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","02509","MTYY","07799","BK4588","BK4007","MST","BK4139","MSTZ","BK4539","BK4595","BK4596","SMI3.UK","WNTR","BK4516","07399","MSOO","MSTX","3LMI.UK","MSTP","BK4585","MSST","MSTW","BK4600","SMST","09799","LMI3.UK","MSII","09399","APED","MSTY","MSDD","IMST","MSTY.UK","3SMI.UK","MSTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179351235","title":"QYUNS-B Reports Over 400% Revenue Surge in 2025, Swings to Adjusted Profit of 356 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1179351235","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179351235?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:09","pubTimestamp":1774616942,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced its 2025 financial results, reporting revenue of approximately 807 million yuan, an increase of about 4.08 times year-over-year. Gross profit reached about 714 million yuan,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821910","title":"Qyuns Therapeutics - FY Revenue RMB807 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622821910?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:46","pubTimestamp":1774615581,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621053696","title":"Qyuns Therapeutics Invests 100 Million Yuan in Wealth Management Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2621053696","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621053696?lang=en_us&edition=fundamental","pubTime":"2026-03-24 13:40","pubTimestamp":1774330813,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said it invested 100 million yuan in a wealth management product offered by Shanghai Pudong Development Bank, according to a Hong Kong bourse filing Monday.Shares of the biopharmaceutical company gained over 3% in afternoon trade Tuesday.The product matures Sept. 23 and offers a guaranteed yield of 0.95% and a floating yield of 0% or 1.05% in the mid range or 1.25% in the high range.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","LENZ","BK1161","BK4139","02509","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621922707","title":"BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2621922707","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621922707?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:21","pubTimestamp":1774279285,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million PrincipalMarch 23  - Qyuns Therapeutics Co Ltd 2509.HK:TO SUBSCRIBE FOR PDB WEALTH MANAGEMENT PRODUCT WITH RMB100 MILLION PRINCIPALFurther company coverage: 2509.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140999385","title":"QYUNS-B (02509) Invests 100 Million Yuan in Wealth Management Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1140999385","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140999385?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:18","pubTimestamp":1774275495,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on March 23, 2026, the company entered into a subscription agreement with SPD Bank to purchase a wealth management product. The move is aimed at efficiently utilizing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621701610","title":"Qyuns Therapeutics Co Ltd - to Subscribe for Pdb Wealth Management Product With RMB100 Mln Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2621701610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621701610?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:59","pubTimestamp":1774274355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111183599","title":"GTHT Securities Initiates Coverage on QYUNS-B with \"Buy\" Rating, Highlights Focus on Autoimmune Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1111183599","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111183599?lang=en_us&edition=fundamental","pubTime":"2026-03-12 09:26","pubTimestamp":1773278789,"startTime":"0","endTime":"0","summary":"GTHT Securities has issued a research report initiating coverage on QYUNS-B (02509) with a \"Buy\" rating. The company concentrates on developing biologic therapies for autoimmune and allergic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","BK1161","02509","BK1147","BK1564","02611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618884289","title":"Qyuns Therapeutics' Arthritis Drug Crusekitug Accepted for Review in China; Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618884289","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618884289?lang=en_us&edition=fundamental","pubTime":"2026-03-10 12:30","pubTimestamp":1773117006,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics (HKG:2509) said its injectable spinal arthritis drug, crusekitug, was accepted for review in China, according to a Hong Kong bourse filing Monday.Shares of the biopharmaceutical firm were up over 11% in late morning trade Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4539","BK4007","BK1161","BK4139","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618947620","title":"BRIEF-Qyuns Therapeutics Says New Drug Application Of Crusekitug (Qx002n) Accepted By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947620","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947620?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:33","pubTimestamp":1773070401,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Says New Drug Application Of Crusekitug  Accepted By NMPAMarch 9  - Qyuns Therapeutics Co Ltd 2509.HK:NEW DRUG APPLICATION OF CRUSEKITUG  FOR TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS IN ADULTS ACCEPTED BY NMPAFurther company coverage: 2509.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX1BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174716224","title":"QYUNS-B (02509) Gains NMPA Acceptance for Lusekizumab (QX002N) New Drug Application Targeting Active Ankylosing Spondylitis in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1174716224","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174716224?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:07","pubTimestamp":1773065274,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that the New Drug Application for its self-developed Lusekizumab injection (an anti-IL-17A monoclonal antibody, R&D code: QX002N) was accepted by the National Medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618624990","title":"Qyuns Therapeutics’ Crusekitug NDA for adult ankylosing spondylitis accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2618624990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618624990?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:01","pubTimestamp":1773064881,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics said China’s National Medical Products Administration accepted its new drug application for Crusekitug  to treat active ankylosing spondylitis in adults. The application is supported by a Phase III trial  that reported 52-week efficacy and safety results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL1W572Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618992624","title":"Qyuns Therapeutics Co Ltd - New Drug Application of Crusekitug (QX002n) for Treatment of Active Ankylosing Spondylitis in Adults Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2618992624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618992624?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:01","pubTimestamp":1773064878,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX1BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172684046","title":"QYUNS-B (02509) Announces Monthly Return for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1172684046","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172684046?lang=en_us&edition=fundamental","pubTime":"2026-03-05 17:34","pubTimestamp":1772703273,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. reported that, as of 28 February 2026, its authorized share capital remained at 227.07 million shares with a par value of RMB 1, totaling RMB 227.07 million. Issued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}]}}